About
Periodic safety update report single assessments (PSUSAs) are single assessments of related periodic safety update reports (PSURs) for active substances contained in medicines authorised in the European Union (EU). A PSUR is a pharmacovigilance report submitted regularly by a marketing-authorisation holder at defined time points following a medicine's authorisation.
Key facts
- Active substance(s) in scope of the PSUSA procedure
- Triptorelin
- Procedure number
- PSUSA/00003048/202203
- Regulatory outcome
- Variation
Documents
Triptorelin : List of nationally authorised medicinal products - PSUSA/00003048/202203
English (EN) (732.81 KB - PDF)
Triptorelin : CMDh Scientific conclusions and grounds for variation, amendments to the Product Information and timetable for the implementation - PSUSA/00003048/202203
English (EN) (86.74 KB - PDF)
български (BG) (105.56 KB - PDF)
español (ES) (90.12 KB - PDF)
čeština (CS) (165.83 KB - PDF)
dansk (DA) (94.79 KB - PDF)
Deutsch (DE) (97.17 KB - PDF)
eesti keel (ET) (72.23 KB - PDF)
ελληνικά (EL) (155.39 KB - PDF)
français (FR) (153.17 KB - PDF)
hrvatski (HR) (108.79 KB - PDF)
íslenska (IS) (90.1 KB - PDF)
italiano (IT) (123.76 KB - PDF)
latviešu valoda (LV) (98.98 KB - PDF)
lietuvių kalba (LT) (136.28 KB - PDF)
magyar (HU) (129.8 KB - PDF)
Malti (MT) (118.61 KB - PDF)
Nederlands (NL) (135.32 KB - PDF)
norsk (NO) (100.04 KB - PDF)
polski (PL) (183.89 KB - PDF)
português (PT) (47.95 KB - PDF)
română (RO) (132.76 KB - PDF)
slovenčina (SK) (163.13 KB - PDF)
slovenščina (SL) (152.1 KB - PDF)
Suomi (FI) (69.77 KB - PDF)
svenska (SV) (93.54 KB - PDF)